Page last updated: 2024-11-07

metaraminol and Ventricular Dysfunction

metaraminol has been researched along with Ventricular Dysfunction in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.

Research Excerpts

ExcerptRelevanceReference
"Ventricular ectopy appeared (or ventricular ectopic beats increased by > 100%) in 13/43 patients."1.30Segmental wall motion abnormalities alter vulnerability to ventricular ectopic beats associated with acute increases in aortic pressure in patients with underlying coronary artery disease. ( Goudevenos, J; Graekas, G; Liapi, G; Pappas, S; Sideris, DA; Siogas, K, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siogas, K1
Pappas, S1
Graekas, G1
Goudevenos, J1
Liapi, G1
Sideris, DA1

Other Studies

1 other study available for metaraminol and Ventricular Dysfunction

ArticleYear
Segmental wall motion abnormalities alter vulnerability to ventricular ectopic beats associated with acute increases in aortic pressure in patients with underlying coronary artery disease.
    Heart (British Cardiac Society), 1998, Volume: 79, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Aorta; Blood Pressure; Cardiac Catheterization; Chi-Square Distri

1998